Being Tactical = Mo...
Health Care: Drugs
Palatin Technologies Inc. (PTN: AMEX)
$0.68 0.00 | 0.75%
02/09/12 - 03:58 PM ET
53.27K / 68.40K
Vol / Avg. Vol:0.64 / 0.67
Open / Prev. Close:0.62 - 0.68
Today's Range:0.39 - 1.38
52 Wk Range:66.71%
Performance YTD:TheStreet Rating:
Portfolios with PTN
- Portfolio NameUser Type
- UserCURRENT#1
- Userjrc1947
- Usercny29
- UserFlytrapz Portfolio 1
- UserHardways_R1
- UserMDM
- Userpepe81 Portfolio 1
- Userelectrksparky
- Usern1
- Useralonzov Portfolio 1
Latest PTN Headlines from TheStreet
- Palatin Technologies CEO Discusses F1Q12 Results - Earnings Call Transcript 11.15.11 | 03:11 pm
- Palatin Technologies CEO Discusses F4Q2011 Results - Earnings Call Transcript 09.22.11 | 04:09 pm
- Palatin Technologies CEO Discusses F3Q2011 Results - Earnings Call Transcript 05.16.11 | 04:05 pm
- Palatin Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript 02.24.11 | 01:02 pm
- Palatin Technologies CEO Discusses F1Q2011 Results - Earnings Call Transcript 11.16.10 | 05:11 pm
- Globecomm Systems - Upgrades & Downgrades 09.30.10 | 11:09 am
- Palatin CEO Discusses F4Q2010 Results - Earnings Call Transcript 09.27.10 | 02:09 pm
- Bill Gross Buys Into Pimco Funds 05.24.10 | 11:05 am
- Palatin Technologies, Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript 05.13.10 | 02:05 pm
- Friday's Health Winners & Losers 11.09.07 | 04:11 pm
Press Releases for PTN
- Palatin Technologies To Present At 14th Annual BIO CEO & Investor Conference - PR Newswire 02.09.12 | 07:02 am
- Palatin Technologies Receives $1.1 Million From Sale Of New Jersey State Tax Credits - PR Newswire 01.17.12 | 07:01 am
- Palatin Technologies To Present At BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference - PR Newswire 01.16.12 | 07:01 am
- Palatin Technologies To Present At Windhover's Therapeutic Area Partnerships Conference - PR Newswire 11.30.11 | 07:11 am
- Palatin Technologies To Present At 10th Annual BIO Investor Forum - PR Newswire 10.21.11 | 07:10 am
- Palatin Technologies, Inc. To Present At The Rodman & Renshaw Annual Global Investment Conference - PR Newswire 09.09.11 | 07:09 am
- Palatin Announces Commencement Of A Phase 1 Trial For Obesity Compound In Collaboration With AstraZeneca - PR Newswire 08.04.11 | 07:08 am
- Palatin Technologies, Inc. Initiates Enrollment In Phase 2b Trial With Bremelanotide In Women With Female Sexual Dysfunction - PR Newswire 06.28.11 | 07:06 am
- Alan Dunton, M.D., Joins Board Of Directors Of Palatin Technologies, Inc. - PR Newswire 06.23.11 | 07:06 am
- Palatin Technologies, Inc. Issued U.S. Patent For Key Component In PL-3994 Drug Candidate - PR Newswire 06.21.11 | 07:06 am
Partner Headlines for PTN
- Palatin Technologies CEO Buys 50,000 Shares of PTN - Benzinga 03.03.11 | 04:03 pm
- Palatin Technologies, Inc. Announces Proposed Offering of Common Stock and Warrants - Benzinga 02.23.11 | 04:02 pm
- Palatin Announces Strategic Realignment of Operations - Benzinga 09.24.10 | 04:09 pm
